Tiny Trevena returns to FDA in second bid for controversial opioid painkiller

Tiny Trevena returns to FDA in second bid for controversial opioid painkiller

Submitted by admin on March 6, 2020 - 10:41am
Source: 
Endpoints
News Tags: 
Trevena
FDA
opioids
painkillers
oliceridine
Headline: 
Tiny Trevena returns to FDA in second bid for controversial opioid painkiller
snippet: 

A year and a half after being rebuffed, microcap biotech Trevena is heading back to the FDA in a second bid to win approval for its opioid painkiller.

Do Not Allow Advertisers to Use My Personal information